Crystal Structures of Inhibitor Complexes of Human T-Cell Leukemia Virus (HTLV-1) Protease
- 1 August 2010
- journal article
- research article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 401 (4) , 626-641
Abstract
No abstract availableKeywords
Funding Information
- Office of Science
- National Institutes of Health
- Basic Energy Sciences (W-31-109-Eng-38)
- U.S. Department of Energy
- Ministry of Education, Culture, Sports, Science and Technology
- National Cancer Institute (HHSN261200800001E)
This publication has 33 references indexed in Scilit:
- Pathological crystallography: case studies of several unusual macromolecular crystalsActa Crystallographica Section D Structural Biology, 2005
- Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensionsActa Crystallographica Section D Structural Biology, 2004
- Coot: model-building tools for molecular graphicsActa Crystallographica Section D Structural Biology, 2004
- Efficacy and mechanism of action of the proteasome inhibitor PS-341 in T-cell lymphomas and HTLV-I associated adult T-cell leukemia/lymphomaOncogene, 2004
- Design of inhibitors against HIV, HTLV-I, and Plasmodium falciparum aspartic proteasesBiological Chemistry, 2004
- Refinement of Macromolecular Structures by the Maximum-Likelihood MethodActa Crystallographica Section D Structural Biology, 1997
- HUMAN T CELL LEUKEMIA VIRUS TYPE I (HTLV-I) AND HUMAN DISEASESAnnual Review of Immunology, 1997
- [20] Processing of X-ray diffraction data collected in oscillation mode1997
- STRUCTURE-BASED INHIBITORS OF HIV-1 PROTEASEAnnual Review of Biochemistry, 1993
- Free R value: a novel statistical quantity for assessing the accuracy of crystal structuresNature, 1992